Open-label Phase II Study of Induction Treatment With Folfoxiri Plus Bevacizumab Followed by Preoperative Chemoradiotherapy Plus Bevacizumab in Patients With Locally Advanced, Resectable Rectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms TRUST
- 12 Mar 2018 Status changed from recruiting to completed.
- 08 Jan 2018 Planned End Date changed from 1 Oct 2017 to 1 Mar 2018.
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History